semaglutide and iud Can the new diabetes weight loss drugs affect reproductive health? — Those Nerdy Girls Are GLP-1s affecting your birth

Emotionally, this creates a hard choice for patients who feel better overall but are troubled by new digestive discomfort

Our medications are subjected to rigorous testing, encompassing potency, pH levels, sterility, and endotoxicity checks to ensure efficacy and safety

Retatrutide is an investigational peptide that acts as a triple agonist at GIP, GLP-1, and glucagon receptors, currently in clinical development for obesity and type 2 diabetes (Jastreboff et al

This study enrolled 3,533 participants who received either semaglutide (1 mg) or a placebo along with standard care

Independent lab analysis has found these products contain undeclared ingredients including diuretics, stimulants, and previously-banned weight-loss compounds (sibutramine analogues) and have caused hospitalizations

Keeping a food and symptom journal during the first few weeks helps separate actual physiological changes from expectation-driven perception